This study confirms previous observations of an increased risk of pump thrombosis with the HeartMate II LVAD beginning in 2011. However, this study shows that after a peak in 2012, the risk of pump thrombosis returned to baseline by 2014.
No takes yet. Share an insight, caveat, or question.
Stulak et al. (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: